Fig. 1From: A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activitiesThe chemical structure of YL529 and its interaction with VEGFR3. a The chemical structure of YL529; b and c The interactions between YL529 and VEGFR3 were shown in 3-D structure and 2-D mapBack to article page